quinoxalines has been researched along with mk 2206 in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (71.43) | 24.3611 |
2020's | 2 (28.57) | 2.80 |
Authors | Studies |
---|---|
Ahmed, O; Cohen, EE; Kuo, WL; Lingen, MW; Liu, J; Macleod, KF; Nagilla, M; Sharifi, MN | 1 |
Cong, L; Xia, ZK; Yang, RY | 1 |
Barata, JT; Bertaina, A; Buontempo, F; Cappellini, A; Chiarini, F; Evangelisti, C; Fragoso, R; Locatelli, F; Lonetti, A; Manzoli, L; Martelli, AM; Neri, LM; Oliveira, M; Orsini, E; Pession, A; Simioni, C | 1 |
Haniuda, M; Hosokawa, Y; Hyodo, T; Karnan, S; Konishi, H; Ota, A; Tsuzuki, S; Wahiduzzaman, M; Yamaji, M | 1 |
Bjune, K; Naderi, S; Wierød, L | 1 |
Bowen, JP; Güner, OF; Matesic, DF; Uko, NE | 1 |
Chuang, SJ; Hussain, N; Johanns, M; Kemp, BE; Rider, MH; Steinberg, GR; Vertommen, D | 1 |
1 review(s) available for quinoxalines and mk 2206
Article | Year |
---|---|
Akt Pathway Inhibitors.
Topics: Antineoplastic Agents; Benzylamines; Cell Line, Tumor; Diamines; Drug Design; Heterocyclic Compounds, 3-Ring; Humans; Molecular Docking Simulation; Phosphatidylinositol 3-Kinases; Phospholipids; Piperazines; Protein Conformation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyrazoles; Pyrimidines; Pyrroles; Quinoxalines; Signal Transduction; Structure-Activity Relationship; Sulfonamides; Thiadiazoles; Thiophenes | 2020 |
6 other study(ies) available for quinoxalines and mk 2206
Article | Year |
---|---|
p62/SQSTM1 accumulation in squamous cell carcinoma of head and neck predicts sensitivity to phosphatidylinositol 3-kinase pathway inhibitors.
Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents; Autophagy; Autophagy-Related Protein 7; Carcinoma, Squamous Cell; Cell Line, Tumor; Class I Phosphatidylinositol 3-Kinases; Drug Resistance, Neoplasm; Gene Expression; Heterocyclic Compounds, 3-Ring; Humans; Mouth Neoplasms; Mutation; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Quinoxalines; Sequestosome-1 Protein; Sulfonamides; Tissue Array Analysis; Ubiquitin-Activating Enzymes | 2014 |
Targeting the TGF-β receptor with kinase inhibitors for scleroderma therapy.
Topics: Heterocyclic Compounds, 3-Ring; Humans; Imidazoles; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Structure; Molecular Targeted Therapy; Morpholines; Protein Binding; Protein Kinase Inhibitors; Pyrazoles; Quinolines; Quinoxalines; Receptors, Transforming Growth Factor beta; Scleroderma, Systemic | 2014 |
Phosphatidylinositol 3-kinase inhibition potentiates glucocorticoid response in B-cell acute lymphoblastic leukemia.
Topics: Antineoplastic Agents; Apoptosis; B-Lymphocytes; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Child; Child, Preschool; Class I Phosphatidylinositol 3-Kinases; Dexamethasone; Glucocorticoids; Heterocyclic Compounds, 3-Ring; Humans; Isoquinolines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogene Proteins c-akt; Purines; Quinazolinones; Quinoxalines; Thiazolidinediones; Triazines | 2018 |
Novel ATP-competitive Akt inhibitor afuresertib suppresses the proliferation of malignant pleural mesothelioma cells.
Topics: Antineoplastic Agents; Apoptosis; Benzylamines; Caspase 3; Caspase 7; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Forkhead Box Protein O1; G1 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Glycogen Synthase Kinase 3 beta; Heterocyclic Compounds, 3-Ring; Heterocyclic Compounds, 4 or More Rings; Humans; Imidazoles; Inhibitory Concentration 50; Mesothelioma; Oxadiazoles; Phosphorylation; Phosphorylcholine; Pleural Neoplasms; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyrazoles; Pyridines; Pyrimidines; Pyrroles; Quinoxalines; Sulfonamides; Thiadiazoles; Thiophenes | 2017 |
Inhibitors of AKT kinase increase LDL receptor mRNA expression by two different mechanisms.
Topics: Aminopyridines; Animals; Benzimidazoles; CHO Cells; Cricetinae; Cricetulus; Hep G2 Cells; Heterocyclic Compounds, 3-Ring; Humans; Imidazoles; Phosphorylcholine; Piperidines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyrazoles; Pyrimidines; Pyrroles; Quinoxalines; Receptors, LDL; Ribonucleosides; RNA Stability; RNA, Messenger; Transcriptional Activation | 2019 |
Effects of PKB/Akt inhibitors on insulin-stimulated lipogenesis and phosphorylation state of lipogenic enzymes in white adipose tissue.
Topics: Acetyl-CoA Carboxylase; Adipocytes; Adipose Tissue, White; Animals; Benzylamines; Heterocyclic Compounds, 3-Ring; Insulin; Lipogenesis; Male; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Quinoxalines; Rats; Rats, Wistar | 2020 |